NCT06377501Completed
Feasibility of a Whole-Food, Plant-Based Diet for Patients With Low-Risk Chronic Lymphocytic Leukemia (CLL)
Feasibility of a Whole-Food, Plant-Based Dietary Intervention for Patients With Low-Risk Chronic Lymphocytic Leukemia
Source: ClinicalTrials.gov · Last updated 2 Sept 2025
Brief summary (registry, in English)
This study will evaluate the feasibility of an 8-week vegan whole-food, plant-based dietary intervention in subjects with low risk CLL who are undergoing observation. Over the course of 8 weeks, participants will attend weekly group cooking classes via Zoom lead by a RD. Participants will also attend weekly individual meetings with a health coaches to assist with adherence to the dietary intervention.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 19 (actual)
- First submitted
- 5 Apr 2023
- Start date
- 7 Mar 2023
- Primary completion date
- 1 Jul 2024
- Lead sponsor
- University of California, San Diego
- Diseases
- Chronic lymphocytic leukaemia
- NCT number
- NCT06377501
What you commit to
- Study type: Interventional
- Participants enrolled: 19
- From 7 Mar 2023 to the primary completion date, 1 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Have active disease and are currently receiving pharmacologic treatment for CLL
- Have previously received treatment for CLL
- A previous or current diagnosis of disordered eating including anorexia, bulimia, binge eating disorder or avoidant/restrictive food intake disorder.
Other illness
- A diagnosis of Type 1 diabetes
- A diagnosis of Insulin dependent type 2 diabetes
Other
- Are currently following a vegan or vegetarian diet
- Currently pregnant or planning to become pregnant
Who the study is looking for
- Patients who have a diagnosis of low-risk CLL according to the modified Rai staging criteria for a minimum of 12 months and are currently undergoing observation.
- Access to a computer or tablet and Zoom.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UC San Diego Coordinator of this site? Confirm its status | San Diego | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.